Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 1/2008

01-03-2008

Refinement of diagnosis and disease classification in psychiatry

Author: Yves Lecrubier

Published in: European Archives of Psychiatry and Clinical Neuroscience | Special Issue 1/2008

Login to get access

Abstract

Knowledge concerning the classification of mental disorders progressed substantially with the use of DSM III-IV and IDCD 10 because it was based on observed data, with precise definitions. These classifications a priori avoided to generate definitions related to etiology or treatment response. They are based on a categorical approach where diagnostic entities share common phenomenological features. Modifications proposed or discussed are related to the weak validity of the classification strategy described above. (a) Disorders are supposed to be independent but the current coexistence of two or more disorders is the rule; (b) They also are supposed to have stability, however anxiety disorders most of the time precede major depression. For GAD age at onset, family history, biology and symptomatology are close to those of depression. As a consequence broader entities such as depression-GAD spectrum, panic-phobias spectrum and OCD spectrum including eating disorders and pathological gambling are taken into consideration; (c) Diagnostic categories use thresholds to delimitate a border with normals. This creates “subthreshold” conditions. The relevance of such conditions is well documented. Measuring the presence and severity of different dimensions, independent from a threshold, will improve the relevance of the description of patients pathology. In addition, this dimensional approach will improve the problems posed by the mutually exclusive diagnoses (depression and GAD, schizophrenia and depression); (d) Some disorders are based on the coexistence of different dimensions. Patients may present only one set of symptoms and have different characteristics, evolution and response to treatment. An example would be negative symptoms in Schizophrenia; (e) Because no etiological model is available and most measures are subjective, objective measures (cognitive, biological) and genetics progresses created important hopes. None of these measures is pathognomonic and most appear to be related to risk factors especially at certain periods when associated with environmental events. One of the major aims for a classification of patients is to identify groups to whom a best possible therapeutic strategy can be proposed. Drugs may improve fear extinction while the genetic and/or acquired avoidance may be called phobia. The basic mechanism and or the corresponding phenotype should appear in the classification. Progresses in early identification of disturbances by taking into account all the information available (prodromal symptoms, cognitive, biological, imaging, genetic, family information) are crucial for the future therapeutic strategy: prevention.
Literature
1.
go back to reference APA (1994) Diagnostic and statistical manual of mental disorders DSM-IV. American Psychiatric Association, Washington APA (1994) Diagnostic and statistical manual of mental disorders DSM-IV. American Psychiatric Association, Washington
2.
go back to reference APA (2000) Diagnostic criteria from DSM-IV-TR. American Psychiatric Association, Washington APA (2000) Diagnostic criteria from DSM-IV-TR. American Psychiatric Association, Washington
3.
go back to reference Balázs J, Bitter I, Lecrubier Y, Csiszér N, Ostorharics G (2000) Prevalence of subthreshold forms of psychiatric disorders in persons making suicide attempts in Hungary. Eur Psychiatry 15(6):354–361PubMedCrossRef Balázs J, Bitter I, Lecrubier Y, Csiszér N, Ostorharics G (2000) Prevalence of subthreshold forms of psychiatric disorders in persons making suicide attempts in Hungary. Eur Psychiatry 15(6):354–361PubMedCrossRef
4.
go back to reference Cannon M, Jones PB, Murray RM (2002) Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159:1080–1092PubMedCrossRef Cannon M, Jones PB, Murray RM (2002) Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159:1080–1092PubMedCrossRef
5.
go back to reference Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P (2002) A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159(4):539–545PubMedCrossRef Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P (2002) A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159(4):539–545PubMedCrossRef
6.
go back to reference Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5–HTT gene. Science 301(5631):386–389PubMedCrossRef Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5–HTT gene. Science 301(5631):386–389PubMedCrossRef
7.
go back to reference Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57(10):1117–1127PubMedCrossRef Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57(10):1117–1127PubMedCrossRef
8.
go back to reference First MB (2005) Mutually Exclusive versus co-occuring diagnostic categories: the challenge of diagnostic comorbidity. Psychopathology 38(4):206–210PubMedCrossRef First MB (2005) Mutually Exclusive versus co-occuring diagnostic categories: the challenge of diagnostic comorbidity. Psychopathology 38(4):206–210PubMedCrossRef
9.
go back to reference Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression. Treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61(1):34–41PubMedCrossRef Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression. Treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61(1):34–41PubMedCrossRef
10.
go back to reference Gould TD, Gottesman II (2006) Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 5(2):113–9PubMedCrossRef Gould TD, Gottesman II (2006) Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 5(2):113–9PubMedCrossRef
11.
go back to reference Harvey PD, Keefe RS (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158(2):176–184PubMedCrossRef Harvey PD, Keefe RS (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158(2):176–184PubMedCrossRef
12.
go back to reference Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW (2006) Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Arch Gen Psychiatry 63(3):298–304PubMedCrossRef Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW (2006) Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Arch Gen Psychiatry 63(3):298–304PubMedCrossRef
13.
go back to reference Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB (1998) Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50(2–3):97–108PubMedCrossRef Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB (1998) Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50(2–3):97–108PubMedCrossRef
14.
go back to reference Kapur S, Mizrahi R, Li M (2005) From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 79(1):59–68PubMedCrossRef Kapur S, Mizrahi R, Li M (2005) From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 79(1):59–68PubMedCrossRef
15.
go back to reference Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49(4):603–615PubMedCrossRef Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49(4):603–615PubMedCrossRef
16.
go back to reference Kendler KS (2006) Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry 163(7):1138–1146PubMedCrossRef Kendler KS (2006) Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry 163(7):1138–1146PubMedCrossRef
17.
go back to reference Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry 51:8–19PubMed Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry 51:8–19PubMed
18.
go back to reference Kessler RC, Nelson CB, Mcgonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US national comorbidity survey. Br J Psychiatry 168(30):17–30 Kessler RC, Nelson CB, Mcgonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US national comorbidity survey. Br J Psychiatry 168(30):17–30
19.
go back to reference Kirkpatrick B, Fenton WS, Carpenter WT, Marder SR (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 32(2):214–219PubMedCrossRef Kirkpatrick B, Fenton WS, Carpenter WT, Marder SR (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 32(2):214–219PubMedCrossRef
20.
go back to reference Larsen TK, Friis S, Haahr U, Joa I, Johannessen JO, Melle I, Opjordsmoen S, Simonsen E, Vaglum P (2001) Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 103(5):323–334PubMedCrossRef Larsen TK, Friis S, Haahr U, Joa I, Johannessen JO, Melle I, Opjordsmoen S, Simonsen E, Vaglum P (2001) Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 103(5):323–334PubMedCrossRef
21.
go back to reference Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D’Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93(17):9235–9240PubMedCrossRef Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D’Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93(17):9235–9240PubMedCrossRef
22.
go back to reference Lecrubier Y (2001) The influence of comorbidity on the prevalence of suicidal behavior. Eur Psychiatry 16:395–399PubMedCrossRef Lecrubier Y (2001) The influence of comorbidity on the prevalence of suicidal behavior. Eur Psychiatry 16:395–399PubMedCrossRef
23.
go back to reference Lecrubier Y (1993) The importance of national therapeutic strategies for the treatment of subthreshold depressive disorders. Eur Psychiatry 8(5):233–234 Lecrubier Y (1993) The importance of national therapeutic strategies for the treatment of subthreshold depressive disorders. Eur Psychiatry 8(5):233–234
24.
go back to reference Lecrubier Y, Sheehan DV, Weiller E, Armorin P, Bonara I, Sheehan KH, Janavs J, Dunbar GC (1997) The mini international neuropsychiatric interview (MINI) a short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 12(5):224–231CrossRef Lecrubier Y, Sheehan DV, Weiller E, Armorin P, Bonara I, Sheehan KH, Janavs J, Dunbar GC (1997) The mini international neuropsychiatric interview (MINI) a short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 12(5):224–231CrossRef
26.
go back to reference Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45:651–660PubMedCrossRef Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45:651–660PubMedCrossRef
27.
go back to reference Mc Gurk SR, Meltzer HY (2000) The role of cognition in vocational functioning in schizophrenia. Schizophr Res 45(3):175–184CrossRef Mc Gurk SR, Meltzer HY (2000) The role of cognition in vocational functioning in schizophrenia. Schizophr Res 45(3):175–184CrossRef
28.
go back to reference Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T (2004) Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 61(2):143–150PubMedCrossRef Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T (2004) Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 61(2):143–150PubMedCrossRef
29.
go back to reference Meltzer HY, McGurk SR (1999) The effects of clozapine, ripseridone and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25(2):233–255PubMed Meltzer HY, McGurk SR (1999) The effects of clozapine, ripseridone and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25(2):233–255PubMed
30.
go back to reference Montgomery SA, Van Zwieten-Boot B (2007) ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004. Eur Neuropsychopharmacol 17:70–77PubMedCrossRef Montgomery SA, Van Zwieten-Boot B (2007) ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004. Eur Neuropsychopharmacol 17:70–77PubMedCrossRef
31.
go back to reference Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 185:291–297PubMedCrossRef Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 185:291–297PubMedCrossRef
32.
go back to reference Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995) Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25(6):1171–1180PubMedCrossRef Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995) Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25(6):1171–1180PubMedCrossRef
33.
go back to reference Pedersen CB, Mortensen PB (2001) Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 58(11):1039–1046PubMedCrossRef Pedersen CB, Mortensen PB (2001) Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 58(11):1039–1046PubMedCrossRef
34.
go back to reference Phillips KA, Kaye WH (2007) The relationship of body dysmorphic disorder and eating disorders to obsessive-compulsive disorder. CNS Spectr 12(5):347–358PubMed Phillips KA, Kaye WH (2007) The relationship of body dysmorphic disorder and eating disorders to obsessive-compulsive disorder. CNS Spectr 12(5):347–358PubMed
35.
go back to reference Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF (1998) Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 173(34):24–28 Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF (1998) Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 173(34):24–28
36.
go back to reference Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M (2004) Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61(11):1136–1144PubMedCrossRef Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M (2004) Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61(11):1136–1144PubMedCrossRef
37.
go back to reference Rickels K, Downing R, Schweizer R, Hassman H (1993) Antidepressants for the treatment of imipramine, trazodone and diazepam. Arch Gen Psychiatry 50:884–895PubMed Rickels K, Downing R, Schweizer R, Hassman H (1993) Antidepressants for the treatment of imipramine, trazodone and diazepam. Arch Gen Psychiatry 50:884–895PubMed
38.
go back to reference Robins LN, Wing J, Wittchen H-U, Helzer JE (1988) The composite international diagnostic interview: an epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069–1077PubMed Robins LN, Wing J, Wittchen H-U, Helzer JE (1988) The composite international diagnostic interview: an epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069–1077PubMed
39.
go back to reference Size and burden of mental disorders in Europe (2005) European Neuropsychopharmacology 15(4):355–490 Size and burden of mental disorders in Europe (2005) European Neuropsychopharmacology 15(4):355–490
40.
go back to reference Selten JP, Cantor-Graae E (2005) Social defeat: risk factor for schizophrenia? Br J Psychiatry 187:101–102PubMedCrossRef Selten JP, Cantor-Graae E (2005) Social defeat: risk factor for schizophrenia? Br J Psychiatry 187:101–102PubMedCrossRef
41.
go back to reference Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S (2004) Limbic-frontal circuitry in major depression: a path modelling metanalysis. Neuroimage 22:409–418PubMedCrossRef Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S (2004) Limbic-frontal circuitry in major depression: a path modelling metanalysis. Neuroimage 22:409–418PubMedCrossRef
42.
go back to reference Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J, Weiller E, Keskiner A, Schinka J, Knapp E, Sheehan MF, Dunbar GC (1997) Reliability and validity of the mini international neuropsychiatric interview (MINI) according to SCID-P. Eur Psychiatry 12(5):232–241CrossRef Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J, Weiller E, Keskiner A, Schinka J, Knapp E, Sheehan MF, Dunbar GC (1997) Reliability and validity of the mini international neuropsychiatric interview (MINI) according to SCID-P. Eur Psychiatry 12(5):232–241CrossRef
43.
go back to reference Watson D (2005) Rethinking the mood and anxiety disorders; a quantitative hierarchical model for DSM-V. J Abnorm Psychol 114(4):522–536PubMedCrossRef Watson D (2005) Rethinking the mood and anxiety disorders; a quantitative hierarchical model for DSM-V. J Abnorm Psychol 114(4):522–536PubMedCrossRef
44.
go back to reference Wittchen H-U, Beesdo K, Bittner A, Goodwin RD (2003) Depressive episodes-evidence for a causal role of primary anxiety disorders? Eur Psychiatry 18:384–393PubMedCrossRef Wittchen H-U, Beesdo K, Bittner A, Goodwin RD (2003) Depressive episodes-evidence for a causal role of primary anxiety disorders? Eur Psychiatry 18:384–393PubMedCrossRef
46.
go back to reference Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH (2003) Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 54(4):453–464PubMedCrossRef Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH (2003) Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 54(4):453–464PubMedCrossRef
47.
go back to reference World Health Organisation (1993) The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. World Health Organisation, Geneva, Swizerland World Health Organisation (1993) The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. World Health Organisation, Geneva, Swizerland
Metadata
Title
Refinement of diagnosis and disease classification in psychiatry
Author
Yves Lecrubier
Publication date
01-03-2008
Publisher
D. Steinkopff-Verlag
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue Special Issue 1/2008
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-007-1003-0

Other articles of this Special Issue 1/2008

European Archives of Psychiatry and Clinical Neuroscience 1/2008 Go to the issue